We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Dr. Andrew Gennery. Clinical Reader in Paediatric Immunology and Haematopoietic Stem Cell Transplantation - Honorary Consultant Paediatric Immunologist, Great North Children's Hospital - Institute of Cellular Medicine, Newcastle University
"Stem cell transplantation in recently described PID"
Haematopoietic stem cell transplantation (HSCT) is an established curative treatment for many primary immunodeficiencies. Advances in donor selection, graft manipulation, conditioning and treatment of complications, mean that survival for many conditions is now around 90%. Next generation sequencing is identifying new immunodeficiencies, many of which are treatable with HSCT. Challenges remain however with short and long-term sequalae. This lecture will review latest developments in HSCT for conventional primary immunodeficiencies and present data on outcome for emerging diseases.
Dr Gennery has worked in the field of primary immunodeficiencies for 20 years and held his current research and clinical position for 15 years. He has published extensively on molecular defects of primary immunodeficiencies, outcome of transplantation and quality of life for different genetic defects, from a centre, national, European and Trans-Atlantic perspective. He is currently chair of ESID Clinical Working Party and chair of ERN-RITA Guidelines working party
Host: Dr. Pere Soler Palacín, Infection in Immunocompromised Pediatric Patients. Vall d'Hebron Research Institute (VHIR) firstname.lastname@example.org
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to email@example.com, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.